Pricing Log in Create free account

GT Biopharma, Inc. (GTBP) vs Palatin Technologies, Inc. (PTN)

GT Biopharma, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. GT Biopharma, Inc. and Palatin Technologies, Inc. are of similar size ($10.2M and $9.4M). GT Biopharma, Inc. trades at the lower P/E: 0.8× against 12.2×. Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against −76.2%. GT Biopharma, Inc. has the higher net margin (0.00% vs −63.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Palatin Technologies, Inc. leads on 9 and GT Biopharma, Inc. on 8.

Valuation

Metric GTBP PTN Biotechnology median
P/E 0.81 12.21 10.26
P/S 121.89 1.23 9.18
P/B 2.05 2.43 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 482.71 0.67 8.98
Earnings yield 122.77% 8.19% (34.89%)
Free cash flow yield (194.98%) (83.75%) (24.52%)

Profitability

Metric GTBP PTN Biotechnology median
Gross margin 41.67% 100.00% 65.16%
Operating margin 0.00% (65.74%) 0.00%
Net margin 0.00% (63.54%) 0.00%
Free cash flow margin 0.00% (103.07%) 0.00%
Return on equity 102.03% (877.60%) (50.12%)
Return on assets (176.27%) (142.11%) (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric GTBP PTN Biotechnology median
Revenue growth (TTM) (76.19%) 110.89% 6.26%
EPS growth (last fiscal year) 3.75% 90.80% 29.88%
Revenue growth, 5-year CAGR 19.67% 156.83% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GTBP PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.61 4.61 4.89
Net debt to EBITDA 0.56 0.87 1.01

Dividend

Metric GTBP PTN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric GTBP PTN Biotechnology median
Market cap 9.36m 10.17m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack